CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- 4 Open-market buy Director bought 2,000 shares at $3.65 ($7,300)
- 4 Open-market buy Director bought 735,000 shares at $4.75 ($3,491,250)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 28,000 shares at an average $4.51 ($126,400)
- 8-K Event Material agreement · New debt or obligation
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,798 shares (to pay taxes)
- 4 Shares withheld for taxes GENERAL COUNSEL gave up 1,127 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 4,728 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 5,104 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
Page 13 of 19 · 378 filings